Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Effective Licensing and Commercialisation of Drug Delivery Systems 2006
Dedicated to the drug delivery sector, this report offers a concise and focused means of assessing and benchmarking drug delivery deal making activity over the past 9 years. It details valuation methodologies and explores effective deal structuring to ensure maximum returns. It is a critical report for all those involved in deal making across both the pharmaceutical and biotechnology sectors. This new edition will provide a completely up-to-date perspective of the drug delivery sector. It includes over 1400 drug delivery deals, over 50 drug delivery contracts and the latest company information.
> Topics covered include:
> Commercialisation strategies
> Key drivers in drug delivery
> Market value
> Trends in deal terms, upfront, milestone and royalty payments
> The drug delivery deals major pharmaceutical companies are doing
> Valuation methods
> Drug delivery deals since 1996
> Drug delivery companies and their technology focus
The report also includes examples of licence agreements.
120+ pages of analysis
50+ tables and figures
Searchable CD-ROM database including:
> 1600+ drug delivery deals
> 140+ drug delivery contracts accessible via the internet
Hard Copy
Table of Contents
Price: $4,950.00 / GBP2,475.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.